Drug pricing regulator NPPA fixes retail costs of 84 drug formulations, Health News, ET HealthWorld

Drug pricing regulator NPPA fixes retail prices of 84 drug formulationsNew Delhi: Drug pricing regulator NPPA has fastened the retail costs for 84 drug formulations, together with these used for therapy of diabetes, headache and hypertension. The National Pharmaceutical Pricing Authority (NPPA) has additionally fastened the costs of formulations indicated to cut back elevated ldl cholesterol and triglycerides ranges, amongst others.

In train of the powers conferred by the Drugs (Prices Control) Order, 2013, the NPPA has fastened the retail costs of the drugs, the regulator stated in a notification.

As per the order, a single pill of Voglibose and (SR) Metformin Hydrochloride will value Rs 10.47, excluding GST.

Similarly, the value of Paracetamol and Caffeine has been fastened at Rs 2.88 per pill. Besides, the value of 1 Rosuvastatin Aspirin and Clopidogrel capsule has been fastened at Rs 13.91.

In a separate notification, NPPA stated it has prolonged the revised ceiling worth of liquid medical oxygen and oxygen inhalation (medicinal gasoline) until September 30 this yr.

The NPPA is remitted to repair/revise the costs of managed bulk medicine and formulations and implement costs and availability of the medicines within the nation. It additionally displays the costs of decontrolled medicine with a view to preserve them at affordable ranges.

The regulator implements and enforces the provisions of the Drugs (Prices Control) Order. It can be entrusted with the duty of recovering quantities overcharged by producers for the managed medicine.

Source hyperlink

Leave a Reply

Your email address will not be published.